학술논문
Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing–Remitting Multiple Sclerosis After Fingolimod Withdrawal.
Document Type
Article
Author
Rollot, Fabien; Couturier, Justine; Casey, Romain; Wiertlewski, Sandrine; Debouverie, Marc; Pelletier, Jean; De Sèze, Jérôme; Labauge, Pierre; Ruet, Aurélie; Thouvenot, Eric; Ciron, Jonathan; Berger, Eric; Gout, Olivier; Clavelou, Pierre; Stankoff, Bruno; Casez, Olivier; Bourre, Bertrand; Zephir, Hélène; Moreau, Thibault; Lebrun-Frenay, Christine
Source
Neurotherapeutics; Mar2022, Vol. 19 Issue 2, p476-490, 15p
Subject
Language
ISSN
19337213
Abstract
Copyright of Neurotherapeutics is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)